Skip to main content
. 2015 Feb 10;9:763–772. doi: 10.2147/DDDT.S75863

Figure 5.

Figure 5

Immunoblotting analysis of Kv4.2 and Cx43.

Notes: (A) Representative immunoblots of homogenate of infarction zones or corresponding zones from control, MI, CMS, model, and fluoxetine group rats probed with anti-Kv4.2 and anti-Cx43 antibody, respectively. Bands indicate position of Kv4.2 (74 kDa), phosphorylated form of Cx43 (43 kDa), nonphosphorylated form of Cx43 (41 kDa), and GAPDH (35 kDa), respectively. (B) Quantitative densitometric analysis of Kv4.2 in the five groups. (C) Quantitative densitometric analysis of phosphorylated form of Cx43 in the five groups. Data are expressed as mean ± standard deviation. *P<0.05 vs control group; #P<0.05 vs model group.

Abbreviations: CMS, chronic mild stress; MI, myocardial infarction; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; au, arbitrary units.